The provisional approval is for two doses of the paediatric Pfizer COVID-19 vaccine, given at least 21 days apart, the health ministry says in a statement
New Zealand’s health regulator Medsafe has granted provisional approval for the Pfizer Inc COVID-19 vaccine for children aged 5 to 11 years old, the health ministry said in a statement.
The provisional approval is for two doses of the paediatric Pfizer COVID-19 vaccine, given at least 21 days apart, it said.
If approved by the Cabinet, the introduction of the paediatric Pfizer vaccine is expected to start in New Zealand no later than the end of January 2022, the ministry said. Reuters
About Medsafe NZ
Medsafe, the New Zealand Medicines and Medical Devices Safety Authority, is the medical regulatory body run by the New Zealand Ministry of Health, administering the Medicines Act 1981 and Medicines Regulations 1984.
Medsafe employs approximately 60 staff members in two offices. The head office, based in Wellington, New Zealand, handles “centralised administrative functions, product approval, and standard settings.” The Investigation and Border Control operates out of the Auckland office